Elsevier

Neuroscience

Volume 72, Issue 2, May 1996, Pages 527-534
Neuroscience

Pre-emptive dynorphin and N-methyl-d-aspartate glutamate receptor antagonism alters spinal immunocytochemistry but not allodynia following complete peripheral nerve injury

https://doi.org/10.1016/0306-4522(95)00495-5Get rights and content

Abstract

The development of chronically painful states following peripheral nerve injury may involve different mechanisms depending on the nature and extent of the nerve lesion. The altered spinal neurochemistry of two substances, the excitatory amino acid glutamate operating via the N-methyl-d-aspartate receptor and the endogenous opioid peptide dynorphin, have been implicated in behavioral sequelae that follow partial peripheral nerve injury. In addition, dynorphin has nonopioid functions which may involve the N-methyl-d-aspartate receptor. We investigated two hypotheses: that the development of mechanical allodynia following complete nerve injury is not greatly influenced by the N-methyl-d-aspartate receptor, and that spinal dynorphin and glutamate expression is interdependent. These studies employed sciatic cryoneurolysis, a complete but transient peripheral nerve injury that results in a delayed mechanical allodynia beginning 21–28 days after injury. Rats were administered dizocipline maleate (MK-801) at 0.25 mg/kg twice per day intraperitoneally from days 0–7 or from days 0–21 post-lesion to pre-emptively block the N-methyl-d-aspartate receptor. In a separate group of rats, an antibody to dynorphin was administered intraperitoneally at 16.6 mg/kg twice per day from days 14 to 21 post-lesion. For all groups, the outcome of allodynia behavior was assessed using von Frey filaments at 42 days post-lesion and the resulting dynorphin and glutamate immunoreactivity in the substantia gelatinosa was measured using proportional area stained and relative optical density, respectively. Only the 0–7 day MK-801 treatment increased the resulting mechanical thresholds significantly (mean ± S.E.M. 7.0 ± 1.2 g) when compared to saline-injected animals (3.9 ± 0.6 g). However, this effect did not prevent allodynia since baseline thresholds were 12 or 15 g for each group. With regard to resulting spinal immunoreactivity, anti-dynorphin antibody treatment significantly increased glutamate immunoreactivity when compared to saline-treated animals (mean relative optical density ± S.E.M. = 807.2 ± 3.6 versus 779.6 ± 8.3, respectively; P =0.01) at 42 days post-lesion.

We conclude that the development of allodynia following sciatic cryoneurolysis peripheral nerve injury involved a minimal contribution from N-methyl-d-aspartate receptor activity. In addition, this study demonstrated that decreasing available dynorphin using antiserum had a significant and lasting effect on spinal glutamate expression without altering the outcome of allodynia. These conclusions suggest that etiological mechanisms leading to pain behaviors are not equal for all nerve injuries, and that altering κ opioid levels can affect glutaminergic pathways at a substantially later time.

Reference (41)

  • HenryJ.L. et al.

    Hyperalgesia following noxious thermal, mechanical, or chemical stimulation involves overlapping spinal mechanisms and interactive participation of excitatory amino acids and neuropeptides

    Am. Pain Soc. J.

    (1994)
  • HyldenJ.L.K. et al.

    Effects of spinal kappa-opioid receptor agonists on the responsiveness of nociceptive superficial dorsal horn neurons

    Pain

    (1991)
  • LimaD. et al.

    Morphological characterization of marginal (lamina I) neurons immunoreactive for substance P, enkephalin, dynorphin and gamma-aminobutyric acid in the rat spinal cord

    J. chem. Neuroanat.

    (1993)
  • LongJ.B. et al.

    Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the K opioid antagonist nor-binaltorphimine

    Brain Res.

    (1989)
  • LucasJ.J. et al.

    Molecular mechanisms of pain: serotonin 1A receptor agonists trigger transactivation by c-fos of the prodynorphin gene in spinal cord neurons

    Neuron

    (1993)
  • MaoJ. et al.

    Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy

    Brain Res.

    (1992)
  • MassardierD. et al.

    A direct non-opiate interaction of dynorphin (1–13) with the N-methyl-d-aspartate (NMDA) receptor

    Eur. J. Pharmac.

    (1989)
  • MellerS.T.

    Thermal and mechanical hyperalgesia: a distinct role for different excitatory amino acid receptors and signal transduction pathways?

    Am. Pain Soc. J.

    (1994)
  • MellerS.T.

    Hyperalgesia: one mechanism or multiple mechanisms?

    Am. Pain Soc. J.

    (1994)
  • NahinR.L. et al.

    Demonstration of dynorphin A 1–8 immunoreactive axons contacting spinal cord projection neurons in a rat model of peripheral inflammation and hyperalgesia

    Pain

    (1992)
  • Cited by (28)

    • Intrathecal morphine-3-glucuronide-induced nociceptive behavior via Delta-2 opioid receptors in the spinal cord

      2016, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      Similarly, dynorphin A(2–17) (3 nmol, i.t.) in mice also induced allodynia (Laughlin et al., 1997; Vanderah et al., 1996a). Pain-related behavior associated with nerve injury is also blocked by an antiserum to dynorphin (Bian et al., 1999; Malan et al., 2000; Wagner and Deleo, 1996; Wang et al., 2001). Dynorphin-converting enzymes, belonging to the cysteine protease family, cleave dynorphin A and dynorphin B between Leu5–Arg6 and Arg6–Arg7 bonds, thereby generating leucine-enkephalin (Leu-ENK) and Leu-ENK-Arg, which are primarily active in δ-opioid receptors (Silberring et al., 1992).

    • Chapter 16 Mechanism of Allodynia Evoked by Intrathecal Morphine-3-Glucuronide in Mice

      2009, International Review of Neurobiology
      Citation Excerpt :

      High doses of dynorphin produce hyperalgesia and allodynia, in contrast to analgesia produced by low doses of dynorphin (Laughlin et al., 1997; Vanderah et al., 1996). Pain‐related behavior associated with nerve injury is also blocked by antiserum to dynorphin (Bian et al., 1999; Malan et al., 2000; Wagner and Deleo, 1996; Wang et al., 2001). The hyperalgesic effect is considered to be independent of the activation of opioid receptors.

    • Chapter 15 Nociceptive Behavior Induced by the Endogenous Opioid Peptides Dynorphins in Uninjured Mice. Evidence with Intrathecal N-Ethylmaleimide Inhibiting Dynorphin Degradation

      2009, International Review of Neurobiology
      Citation Excerpt :

      Another set of evidence supports the notion on the pronociceptive functions of dynorphin A in the spinal cord. Behavioral hyperalgesia as a result of inflammation or tissue injury is accompanied by elevations in spinal dynorphin content (Draisci et al., 1991; Dubner and Ruda, 1992; Iadarola et al., 1988; Kajander et al., 1990; Malan et al., 2000; Riley et al., 1996; Ruda et al., 1988; Wagner and Deleo, 1996). This increase is considered as causative of hyperalgesia and allodynia.

    View all citing articles on Scopus
    View full text